Abbott Laboratories (ABT)vsSight Sciences Inc (SGHT)
ABT
Abbott Laboratories
$104.83
+0.74%
HEALTHCARE · Cap: $180.82B
SGHT
Sight Sciences Inc
$3.85
+6.06%
HEALTHCARE · Cap: $187.40M
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 57199% more annual revenue ($44.33B vs $77.36M). ABT leads profitability with a 14.7% profit margin vs -49.7%. ABT earns a higher WallStSmart Score of 51/100 (C-).
ABT
Buy51
out of 100
Grade: C-
SGHT
Avoid29
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-315.5%
Fair Value
$25.23
Current Price
$104.83
$79.60 premium
Intrinsic value data unavailable for SGHT.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 21.6%
Generating 2.6B in free cash flow
No standout strengths identified
Areas to Watch
Expensive relative to growth rate
Moderate valuation
4.4% revenue growth
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -50.7% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : SGHT
SGHT has a balanced fundamental profile.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, Revenue Growth.
Bear Case : SGHT
The primary concerns for SGHT are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
ABT profiles as a value stock while SGHT is a turnaround play — different risk/reward profiles.
SGHT carries more volatility with a beta of 2.43 — expect wider price swings.
SGHT is growing revenue faster at 6.9% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
ABT scores higher overall (51/100 vs 29/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Sight Sciences Inc
HEALTHCARE · MEDICAL DEVICES · USA
Sight Sciences Inc. (SGHT) is a pioneering medical technology company focused on transforming the management of eye diseases through innovative surgical and non-surgical solutions, particularly targeting glaucoma care. With a robust portfolio of cutting-edge products and a strong intellectual property foundation, the company is strategically positioned to capitalize on the increasing demand for minimally invasive therapies in the ophthalmology sector. As Sight Sciences expands its distribution network and continues to drive advancements in eye care, it presents a compelling investment opportunity for institutional investors looking to engage with the dynamic healthcare market.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?